You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME / CE

At the Leading Edge of ADHD Management: Highlights From a Recent Symposium

  • Authors: Andrew J. Cutler, MD; Ann Childress, MD; Kristin Sohl, MD, FAAP
  • CME / CE Released: 12/28/2022
  • Valid for credit through: 12/28/2023, 11:59 PM EST
Start Activity

  • Credits Available

    Physicians - maximum of 0.75 AMA PRA Category 1 Credit(s)™

    Nurses - 0.75 ANCC Contact Hour(s) (0 contact hours are in the area of pharmacology)

    Pharmacists - 0.75 Knowledge-based ACPE (0.075 CEUs)

    You Are Eligible For

    • Letter of Completion

Target Audience and Goal Statement

This activity is intended for psychiatrists, pediatricians, primary care physicians, nurse practitioners, physician assistants, nurses, pharmacists, psychologists, and other healthcare professionals who provide care to patients with ADHD.

The goal of this activity is for learners to be better able to establish treatment targets for ADHD symptoms and select patients with ADHD who may benefit from multimodal treatment strategies.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Establishment of treatment targets for patients with ADHD
  • Have greater competence related to
    • Identifying patients who may benefit from multimodal treatment approaches
  • Demonstrate intent to act associated with
    • Implementing shared decision-making with patients for consideration of incorporating nonpharmacologic interventions as part of a treatment program


Disclosures

Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.


Moderator

  • Andrew J. Cutler, MD

    Clinical Associate Professor of Psychiatry
    SUNY Upstate Medical University
    Syracuse, New York

    Disclosures

    Andrew J. Cutler, MD, has the following relevant financial relationships:
    Consultant or advisor for: AbbVie; ACADIA Pharmaceuticals, Inc.; Alfasigma USA, Inc.; Alkermes, Inc.; Allergan; BioXcel Therapeutics; Corium International, Inc.; Intra-Cellular Therapies, Inc.; Ironshore; Janssen; Lundbeck; Neumora; Neurocrine Biosciences, Inc.; Noven Pharmaceuticals, Inc.; Otsuka Pharmaceutical Co., Ltd.; Pear Therapeutics; Relmada Therapeutics, Inc.; Sage Therapeutics; Sunovion Pharmaceuticals Inc.; Supernus Pharmaceuticals, Inc.; Takeda; Teva
    Speaker or member of speakers bureau for: AbbVie; ACADIA Pharmaceuticals, Inc.; Alfasigma USA, Inc.; Alkermes, Inc.; Allergan; BioXcel Therapeutics; Corium International, Inc.; Intra-Cellular Therapies, Inc.; Ironshore; Janssen; Lundbeck; Neurocrine Biosciences, Inc.; Noven Pharmaceuticals, Inc.; Otsuka Pharmaceutical Co., Ltd.; Sunovion Pharmaceuticals Inc.; Supernus Pharmaceuticals, Inc.; Takeda; Teva

Panelists

  • Ann Childress, MD

    President
    Center for Psychiatry and Behavioral Medicine, Inc
    Adjunct Faculty
    UNLV School of Medicine
    Touro University of Nevada College of Medicine
    Las Vegas, Nevada

    Disclosures

    Ann Childress, MD, has the following relevant financial relationships:
    Consultant or advisor for: Cingulate; Corium International, Inc.; KemPharm; Noven Pharmaceuticals, Inc.; Otsuka Pharmaceutical Co., Ltd.; Supernus Pharmaceuticals, Inc.
    Speaker or member of speakers bureau for: Corium International, Inc.; Ironshore Pharmaceuticals, Inc.; Shire; Takeda; Tris Pharma, Inc.
    Research funding from: Adlon Therapeutics; Akili Interactive Labs, Inc.; Allergan; Arbor Pharmaceuticals, Inc.; Emalex Biosciences; KemPharm; Otsuka Pharmaceutical Co., Ltd.; Purdue Pharma L.P.; Sunovion Pharmaceuticals Inc.; Supernus Pharmaceuticals, Inc.

  • Kristin Sohl, MD, FAAP

    Professor of Clinical Child Health
    University of Missouri
    Executive Director
    ECHO Autism
    Columbia, Missouri

    Disclosures

    Kristin Sohl, MD, FAAP, has the following relevant financial relationships:
    Consultant or advisor for: Quadrant Biosciences; Cognoa, Inc. (former)
    Research funding from: Cognoa, Inc.

Editor

  • Clinton W. Wright, PharmD, BCPP

    Medical Education Director, Medscape, LLC 

    Disclosures

    Clinton W. Wright, PharmD, BCPP, has no relevant financial relationships. 

Compliance Reviewer/Nurse Planner

  • Lisa Simani, APRN, MS, ACNP

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Lisa Simani, APRN, MS, ACNP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.


Accreditation Statements

Medscape

Interprofessional Continuing Education

In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Contact This Provider

    For Nurses

  • Awarded 0.75 contact hour(s) of nursing continuing professional development for RNs and APNs; 0.00 contact hours are in the area of pharmacology.

    Contact This Provider

    For Pharmacists

  • Medscape designates this continuing education activity for 0.75 contact hour(s) (0.075 CEUs) (Universal Activity Number: JA0007105-0000-22-412-H01-P).

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read about the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or print it out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME / CE

At the Leading Edge of ADHD Management: Highlights From a Recent Symposium

Authors: Andrew J. Cutler, MD; Ann Childress, MD; Kristin Sohl, MD, FAAPFaculty and Disclosures

CME / CE Released: 12/28/2022

Valid for credit through: 12/28/2023, 11:59 PM EST

processing....

Learning Feedback Questions

Please answer these questions to complement your learning experience.

  • Print